Back to ALKEON CAPITAL MANAGEMENT LLC ALKEON CAPITAL MANAGEMENT LLC

RYTMRYTM
14 quarters

Position history for ALKEON CAPITAL MANAGEMENT LLCALKEON CAPITAL MANAGEMENT LLC's holdings in RHYTHM PHARMACEUTICALS INC

ALKEON CAPITAL MANAGEMENT LLC previously held 0 shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$6.2M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$106.76
0
2025-Q3
Unchanged
1M
0.0%
$102.8M0.2%$100.64
0
2025-Q2
Increased
1M
+24.5%
$64.3M0.1%$62.73
43
2025-Q1
Decreased
817,700
-30.0%
$43.3M0.1%$54.80
0
2024-Q4
Unchanged
1.2M
0.0%
$65.4M0.1%$56.34
0
2024-Q3
Increased
1.2M
+16.8%
$61.2M0.1%$51.35
41
2024-Q2
New
1M
-
$41.1M0.1%$41.06
40
2023-Q4
Exited
0
-100.0%
$00.0%$45.97
0
2023-Q3
Unchanged
1.7M
0.0%
$39.5M0.1%$22.92
0
2023-Q2
Decreased
1.7M
-14.4%
$28.4M0.0%$16.71
0
2023-Q1
Decreased
2M
-9.9%
$36M0.1%$17.66
0
2022-Q4
Increased
2.2M
+31.3%
$65.2M0.3%$29.12
45
2022-Q3
Increased
1.7M
+13.7%
$41.8M0.1%$23.87
40
2022-Q2
New
1.5M
-
$6.2M0.0%$4.27
38

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used